Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIR708 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIR708 mRNA | CTD | PMID:30096437 | MIR708 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [2-ethylhexyldiphenylphosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MIR708 mRNA | CTD | PMID:36764644 | MIR708 | Human | aflatoxin B1 | multiple interactions | EXP | | 6480464 | [CYP2A13 protein co-treated with Aflatoxin B1] results in decreased expression of MIR708 mRNA | CTD | PMID:26084420 | MIR708 | Human | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3 and 3-bis(2-aminoethyl)-1-triazene] results in decreased expression of MIR708 mRNA | CTD | PMID:23284745 | MIR708 | Human | arsenite(3-) | multiple interactions | ISO | Mir708 (Rattus norvegicus) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of MIR708 mRNA and [sodium arsenite results in increased abundance of arsenite] which results in increased expression of MIR708 mRNA | CTD | PMID:31555879 | MIR708 | Human | atrazine | increases expression | ISO | Mir708 (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of MIR708 mRNA | CTD | PMID:36841081 | MIR708 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of MIR708 promoter | CTD | PMID:27901495 | MIR708 | Human | bis(2-chloroethyl) sulfide | decreases expression | ISO | Mir708 (Mus musculus) | 6480464 | Mustard Gas results in decreased expression of MIR708 mRNA | CTD | PMID:26456178 | MIR708 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [ovalbumin-alum co-treated with Diethylhexyl Phthalate] results in decreased expression of MIR708 | CTD | PMID:36508822 | MIR708 | Human | cadmium dichloride | increases expression | ISO | Mir708 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of MIR708 mRNA | CTD | PMID:35183672 | MIR708 | Human | carbon atom | increases expression | EXP | | 6480464 | Carbon results in increased expression of MIR708 mRNA | CTD | PMID:26068961 | MIR708 | Human | choline | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR708 mRNA | CTD | PMID:20548288 | MIR708 | Human | cisplatin | increases expression | ISO | Mir708 (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of MIR708 mRNA | CTD | PMID:24880025 | MIR708 | Human | cisplatin | increases expression | ISO | Mir708 (Mus musculus) | 6480464 | Cisplatin results in increased expression of MIR708 mRNA | CTD | PMID:28119452 | MIR708 | Human | dexamethasone | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [2-ethylhexyldiphenylphosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MIR708 mRNA | CTD | PMID:36764644 | MIR708 | Human | dexamethasone | increases expression | ISO | Mir708 (Rattus norvegicus) | 6480464 | Dexamethasone results in increased expression of MIR708 mRNA | CTD | PMID:33619658 | MIR708 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of MIR708 mRNA | CTD | PMID:26842497 | MIR708 | Human | elemental carbon | increases expression | EXP | | 6480464 | Carbon results in increased expression of MIR708 mRNA | CTD | PMID:26068961 | MIR708 | Human | folic acid | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR708 mRNA | CTD | PMID:20548288 | MIR708 | Human | L-methionine | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR708 mRNA | CTD | PMID:20548288 | MIR708 | Human | nickel atom | multiple interactions | ISO | Mir708 (Rattus norvegicus) | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR708 mRNA | CTD | PMID:31734292 | MIR708 | Human | nickel sulfate | multiple interactions | ISO | Mir708 (Rattus norvegicus) | 6480464 | [nickel sulfate results in increased abundance of Nickel] which results in increased expression of MIR708 mRNA | CTD | PMID:31734292 | MIR708 | Human | Octicizer | multiple interactions | ISO | Mir708 (Mus musculus) | 6480464 | [2-ethylhexyldiphenylphosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MIR708 mRNA | CTD | PMID:36764644 | MIR708 | Human | resveratrol | decreases expression | ISO | Mir708 (Rattus norvegicus) | 6480464 | resveratrol results in decreased expression of MIR708 mRNA | CTD | PMID:22050707 | MIR708 | Human | resveratrol | multiple interactions | ISO | Mir708 (Rattus norvegicus) | 6480464 | plastochromanol 8 promotes the reaction [resveratrol results in decreased expression of MIR708 mRNA] and resveratrol promotes the reaction [plastochromanol 8 results in decreased expression of MIR708 mRNA] | CTD | PMID:22050707 | MIR708 | Human | sodium arsenite | multiple interactions | ISO | Mir708 (Rattus norvegicus) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of MIR708 mRNA and [sodium arsenite results in increased abundance of arsenite] which results in increased expression of MIR708 mRNA | CTD | PMID:31555879 | MIR708 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of MIR708 mRNA | CTD | PMID:29207610 | MIR708 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR708 mRNA | CTD | PMID:34032870 | |